These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7667612)

  • 1. Urinary concentration of a specific peptide of type I collagen of bone (CrossLaps): correlation to hydroxyproline.
    Silsand T; Reine A; Dugal S; Lunde T; Smedsrud B; Seeberg T
    Scand J Clin Lab Invest; 1995 Apr; 55(2):187-92. PubMed ID: 7667612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers.
    Peichl P; Griesmacherb A; Marteau R; Hejc S; Kumpan W; Müller MM; Bröll H
    Clin Biochem; 2001 Mar; 34(2):131-9. PubMed ID: 11311223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.
    Christgau S; Rosenquist C; Alexandersen P; Bjarnason NH; Ravn P; Fledelius C; Herling C; Qvist P; Christiansen C
    Clin Chem; 1998 Nov; 44(11):2290-300. PubMed ID: 9799756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P; Gineyts E; Riou JP; Delmas PD
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of urinary CrossLaps as a sensitive marker of bone metabolism.
    Nakayama H; Yano T; Sagara Y; Ando K; Kasai Y; Taketani Y
    Endocr J; 1997 Aug; 44(4):479-84. PubMed ID: 9447279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis.
    de la Piedra C; Traba ML; Dominguez Cabrera C; Sosa Henríquez M
    Clin Chim Acta; 1997 Sep; 265(2):225-34. PubMed ID: 9385464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary bone resorption markers in monitoring treatment of symptomatic osteoporosis.
    Parviainen MT; Jääskeläinen K; Kröger H; Arnala I; Alhava E
    Clin Chim Acta; 1999 Jan; 279(1-2):145-54. PubMed ID: 10064126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis.
    Kawana K; Takahashi M; Hoshino H; Kushida K
    Clin Chim Acta; 2002 Feb; 316(1-2):109-15. PubMed ID: 11750280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of urinary bone resorption markers in women of 40-70 years; day-to-day and long-term variation in individual subjects.
    Gerrits MI; Vecht-Hart IM; Oldenhave A; Thijssen JH
    Maturitas; 1998 Nov; 30(3):247-55. PubMed ID: 9881324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
    Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
    Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolyl-hydroxyproline dipeptide in non-hydrolyzed morning urine and its value in postmenopausal osteoporosis.
    Husek P; Svagera Z; Vsianský F; Franeková J; Simek P
    Clin Chem Lab Med; 2008; 46(10):1391-7. PubMed ID: 18844493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine.
    Gertz BJ; Shao P; Hanson DA; Quan H; Harris ST; Genant HK; Chesnut CH; Eyre DR
    J Bone Miner Res; 1994 Feb; 9(2):135-42. PubMed ID: 8140926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis.
    Delmas PD; Schlemmer A; Gineyts E; Riis B; Christiansen C
    J Bone Miner Res; 1991 Jun; 6(6):639-44. PubMed ID: 1887826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory diagnosis of osteoporosis].
    Schmolke B
    Orthopade; 2001 Jul; 30(7):425-36. PubMed ID: 11515180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-tlopeptides.
    Okabe R; Nakatsuka K; Inaba M; Miki T; Naka H; Masaki H; Moriguchi A; Nishizawa Y
    Clin Chem; 2001 Aug; 47(8):1410-4. PubMed ID: 11468230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment.
    Bonde M; Qvist P; Fledelius C; Riis BJ; Christiansen C
    J Clin Endocrinol Metab; 1995 Mar; 80(3):864-8. PubMed ID: 7883844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
    Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME
    Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of bone turnover in postmenopausal women receiving hormone replacement therapy.
    Hamwi A; Ganem AH; Grebe C; Kerschan-Schindl K; Preisinger E; Boschitsch E; Bieglmayer C
    Clin Chem Lab Med; 2001 May; 39(5):414-7. PubMed ID: 11434391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.